Download >> Download Bcca cancer drug manual online

Read Online >> Read Online Bcca cancer drug manual online

bccancer drug

bcca guidelines

paclitaxel bcca

chemotherapy drug table

chemotherapy drug chart

carboplatin bc cancer

bc cancer agency chemotherapy protocols

bcca drug benefit list

1 Mar 2008 *Ovarian cancer. *Rhabdomyosarcoma. *Soft tissue sarcoma. *Wilm's tumour. *Health Canada approved indication. Adapted from reference 1, 3, 4, and 26 unless specified otherwise. SPECIAL PRECAUTIONS: Inadvertent administration of vincristine by the intrathecal (IT) route is nearly always fatal and is
1 Feb 2017 REFERENCES: 1. Pizzo P, Poplack D. Principles and Practice of Pediatric Oncology. Fourth ed. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 246. 2. Dorr RT, Von-Hoff DD. Drug monographs. Cancer chemotherapy handbook. 2nd ed. Norwalk, Conneticut: Appleton and Lange;. 1994. p. 395-416. 3.
These summaries are those in current use by the Systemic Therapy Program staff at all regional cancer centres. Both the format and content of the summaries will change as they are reviewed and revised on a periodic basis. The date of last revision will be visible at the end of the protocol summary.
1 Jan 2014 Carboplatin is an analog of cisplatin. Like cisplatin, it contains a platinum atom surrounded in a plane by two ammonia groups and two other ligands in the cis position. The other two ligands in carboplatin are present in a ring structure rather than as two chloride atoms in cisplatin. This difference makes
1 Feb 2016 reference source for health care professionals caring for cancer patients. The manual contains concise, evaluative information on oncology drugs recommended for use by the BCCA. Information is presented using a standardized format for consistency and readability. Documents are written by oncology
Fludrocortisone Patient Handout · Fluorouracil INFUSOR™ Patient Handout (Discontinuing INFUSOR™ from a PICC line) · Fluorouracil INFUSOR™ Patient Handout (Discontinuing INFUSOR™ from an IVAD) · Fluorouracil INFUSOR™ Patient Handout (Your INFUSOR™ - A Guide for Patients) · Fluorouracil Monograph.
BC Cancer Agency Cancer Drug Manual©. Page 1 of 7. Sorafenib. Developed: 1 September 2007. Revised: 1 Jan 2010, 1 June 2013, 1 December 2014. DRUG NAME: Sorafenib. SYNONYM(S): sorafenib tosylate,1 BAY 43-90062. COMMON TRADE NAME(S): NEXAVAR®. CLASSIFICATION: multikinase inhibitor1.
This page provides information about oncology drug coverage in BC. The source of funding for cancer medications in BC depends on whether they are being used to actively treat cancer, or for supportive care purposes. Page Content. Go to Reimbursement & Forms
Cancer Drug Manual. The Cancer Drug Manual® provides concise, evaluative information on drugs used in oncology. Inclusion in this index is not an indication of the funding status of a drug through BC Cancer. To determine drug coverage, see Benefit Drug List. ShortPageContent
USER'S GUIDE. Updated: July 1, 2012. The Cancer Drug Manual provides concise, evaluative drug information on drugs used in an oncology setting. The first edition of the Cancer Drug Manual was published by BCCA in 1990, followed by a complete revision in 1994. Since 2001, the Cancer Drug Manual has become a